Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Shares Outstanding (Diluted Average) (2021 - 2024)

Historic Shares Outstanding (Diluted Average) for Bio Essence (BIOE) over the last 4 years, with Q2 2024 value amounting to $38.0 million.

  • Bio Essence's Shares Outstanding (Diluted Average) rose 949.72% to $38.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $38.0 million, marking a year-over-year increase of 949.72%. This contributed to the annual value of $36.0 million for FY2023, which is 892.24% up from last year.
  • Per Bio Essence's latest filing, its Shares Outstanding (Diluted Average) stood at $38.0 million for Q2 2024, which was up 949.72% from $38.0 million recorded in Q1 2024.
  • Bio Essence's Shares Outstanding (Diluted Average)'s 5-year high stood at $38.0 million during Q3 2023, with a 5-year trough of $33.0 million in Q2 2021.
  • Its 4-year average for Shares Outstanding (Diluted Average) is $34.5 million, with a median of $33.0 million in 2021.
  • Per our database at Business Quant, Bio Essence's Shares Outstanding (Diluted Average) changed by 0.0% in 2022 and then surged by 1514.74% in 2023.
  • Bio Essence's Shares Outstanding (Diluted Average) (Quarter) stood at $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022, then increased by 8.92% to $36.0 million in 2023, then grew by 5.72% to $38.0 million in 2024.
  • Its last three reported values are $38.0 million in Q2 2024, $38.0 million for Q1 2024, and $36.0 million during Q4 2023.